Chronic administration of isoorientin to APP/PS1 mice significantly reduced GSK‐3β hyperactivation, tau protein hyperphosphorylation, and Aβ deposition in AD, and led to reverse prolonged synaptic activation and spatial memory impairment [78]. This evidence concerns the gene PSEN1 and Alzheimer disease.